University of Zurich

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1833-04-29

Employees: 5K

Market Cap: -

Website: http://www.uzh.ch

Clinical Trials

Effect of Exercise Training in Patients With Pulmonary Hypertension

Not Applicable

Recruiting

Conditions: Hypertension, Pulmonary

Interventions: Behavioral: respiratory and exercise therapy
Behavioral: respiratory and exercise therapy with supplemental oxygen

First Posted Date: 2015-09-24

Last Posted Date: 2022-11-02

Lead Sponsor: University of Zurich

Target Recruit Count: 32

Registration Number: NCT02558582

Locations: 🇨🇭
UniversityHospital Zurich, Department of Pulmonology, Zurich, Switzerland

Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity

Not Applicable

Completed

Conditions: Addiction

Interventions: Drug: Placebo
Drug: Amisulpride
Drug: Naltrexone

First Posted Date: 2015-09-23

Last Posted Date: 2015-09-23

Lead Sponsor: University of Zurich

Target Recruit Count: 121

Registration Number: NCT02557984

Locations: 🇨🇭
University Hospital, Zurich, Switzerland

Validation of the German Version of the Injustice Experience Questionnaire

Completed

Conditions: Validation Studies

First Posted Date: 2015-09-17

Last Posted Date: 2021-02-17

Lead Sponsor: University of Zurich

Target Recruit Count: 210

Registration Number: NCT02552719

Locations: 🇩🇪
DRK Schmerz-Zentrum Mainz, Mainz, Rheinland-Pfalz, Germany
🇨🇭
ANNR Rehaclinic, Baden, Aargau, Switzerland
🇨🇭
Zentrum für Schmerzmedizin, Schweizer Paraplegiker-Zentrum Nottwil, Nottwil, Luzern, Switzerland

and more 3 locations

iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions

Phase 4

Completed

Conditions: Food Allergy

Interventions: Drug: Placebo
Drug: Omeprazole

First Posted Date: 2015-09-17

Last Posted Date: 2017-05-11

Lead Sponsor: University of Zurich

Target Recruit Count: 44

Registration Number: NCT02552537

Locations: 🇨🇭
University Hospital Zurich, Zurich, Switzerland
🇪🇸
Hospital Clinico San Carlos, Madrid, Spain

Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection

Phase 2

Conditions: Dolutegravir
Monotherapy
Primary HIV Infection
Treatment Efficacy

Interventions: Drug: Dolutegravir
Drug: Standard of care combinational antiretroviral therapy

First Posted Date: 2015-09-16

Last Posted Date: 2018-10-12

Lead Sponsor: University of Zurich

Target Recruit Count: 101

Registration Number: NCT02551523

Locations: 🇨🇭
University Hospital Zurich, University of Zurich, Zurich, Switzerland

HLA Sensitization in Severely Burned Patients

Conditions: Severely Burned Patients

First Posted Date: 2015-09-02

Last Posted Date: 2017-11-21

Lead Sponsor: University of Zurich

Target Recruit Count: 50

Registration Number: NCT02537821

Locations: 🇨🇭
University Hospital Zurich, Zurich, Switzerland

High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy

Phase 4

Terminated

Conditions: Mitral Valve Insufficiency

Interventions: Device: MitraClip®
Procedure: Mitral valve Surgery

First Posted Date: 2015-08-27

Last Posted Date: 2016-09-09

Lead Sponsor: University of Zurich

Target Recruit Count: 294

Registration Number: NCT02534155

Locations: 🇮🇹
San Raffaele Hospital, Milano, Italy
🇩🇪
Asklepios Klinik Hamburg St. Georg, Hamburg, Germany
🇨🇭
Inselspital Bern, Bern, Switzerland

and more 9 locations

Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm

Phase 1

Conditions: Pancreatic Neoplasms
Hepatocellular Cancer
Cholangiocarcinoma
Colorectal Neoplasms

Interventions: Drug: OXY111A

First Posted Date: 2015-08-19

Last Posted Date: 2015-08-19

Lead Sponsor: University of Zurich

Target Recruit Count: 69

Registration Number: NCT02528526

Locations: 🇨🇭
University Hospital Zurich, Visceral Surgery, Zurich, ZH, Switzerland

Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease

Not Applicable

Completed

Conditions: Stable Coronary Heart Disease

Interventions: Dietary Supplement: flavanol-rich drink vs flavanol-free drink

First Posted Date: 2015-08-11

Last Posted Date: 2019-01-11

Lead Sponsor: University of Zurich

Target Recruit Count: 37

Registration Number: NCT02520466

Locations: 🇨🇭
Cardiovascular Center Cardiology Univeristy Hospital of Zurich, Zurich, Switzerland
🇨🇭
Universisty Hospital of Zurich, Cardiovascular Center Cardiology, Zurich, Switzerland

Improvement in Acoustic Voice Characteristics in Functional Dysphonia After Therapy

Completed

Conditions: Functional Voice Disorder

First Posted Date: 2015-08-07

Last Posted Date: 2016-05-16

Lead Sponsor: University of Zurich

Target Recruit Count: 50

Registration Number: NCT02518425

Locations: 🇨🇭
Clinic for Otorhinolaryngology University Hospital Zurich, Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy